WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 319853
CAS#: 835619-41-5
Description: Indeglitazar, also known as PPM-204 and PLX-204, is an orally available peroxisome proliferator-activated receptor (PPAR) pan-agonist for all three PPAR subtypes alpha (α), delta (δ) and gamma under development for for Type 2 diabetes mellitus (T2DM).
MedKoo Cat#: 319853
Name: Indeglitazar
CAS#: 835619-41-5
Chemical Formula: C19H19NO6S
Exact Mass: 389.0933
Molecular Weight: 389.422
Elemental Analysis: C, 58.60; H, 4.92; N, 3.60; O, 24.65; S, 8.23
Synonym: PLX-204; PLX204; PLX 204; PPM-204; PPM204; PPM 204; Indeglitazar
IUPAC/Chemical Name: 3-(5-Methoxy-1-((4-methoxyphenyl)sulfonyl)-1H-indol-3-yl)propanoic acid
InChi Key: YMPALHOKRBVHOJ-UHFFFAOYSA-N
InChi Code: InChI=1S/C19H19NO6S/c1-25-14-4-7-16(8-5-14)27(23,24)20-12-13(3-10-19(21)22)17-11-15(26-2)6-9-18(17)20/h4-9,11-12H,3,10H2,1-2H3,(H,21,22)
SMILES Code: O=C(O)CCC1=CN(S(=O)(C2=CC=C(OC)C=C2)=O)C3=C1C=C(OC)C=C3
1: Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI,
England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M,
Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P,
Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K,
Bollag G, Ibrahim PN, Tobin JF. Scaffold-based discovery of indeglitazar, a PPAR
pan-active anti-diabetic agent. Proc Natl Acad Sci U S A. 2009 Jan
6;106(1):262-7. doi: 10.1073/pnas.0811325106. Epub 2008 Dec 30. PubMed PMID:
19116277; PubMed Central PMCID: PMC2629228.